Position in LLY
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$851,595
+$23,802 QoQ
Shares Held
710
-21.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.64%
of 13F equity value
Holder Rank
#3,283
of 4,605 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Code Waechter LLC holds $5,749,721 across 9 Drug Manufacturers - General names. LLY ranks #2 (14.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
5,102 | $1,283,867 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
710 | $851,595 | |
| 3 | PFE |
Pfizer Inc
|
27,966 | $673,421 | |
| 4 | JNJ |
Johnson & Johnson
|
2,607 | $662,099 | |
| 5 | AMGN |
Amgen Inc
|
1,786 | $646,746 | |
| 6 | SNY |
Sanofi
|
13,905 | $593,187 | |
| 7 | GSK |
GSK plc
|
8,535 | $447,404 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,537 | $320,524 |
All Filings in LLY
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $851,595 | 710 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $827,793 | 900 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $843,623 | 785 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $511,210 | 670 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $355,465 | 456 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $212,258 | 257 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $222,336 | 288 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $373,866 | 422 | Shares | Sole | 2024-10-10 | |
| No filing history on record for this holder in this stock. | ||||||